Skip to content

Clinical efficacy evaluation and mechanism study of acupuncture intervention in frequent tension-type headache

Clinical efficacy evaluation and mechanism study of acupuncture intervention in frequent tension-type headache

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200067224
Enrollment
Unknown
Registered
2022-12-29
Start date
2023-01-01
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Frequent tension-type headache

Interventions

Experimental group:acupuncture
Western medicine control group:oral western medicine
Conventional acupuncture control group:conventional acupuncture

Sponsors

The First Affiliated Hospital of Tianjin University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Patients who meet the diagnostic criteria for frequent tension headache; 2. Obvious tenderness in the head and neck muscles found on palpation; 3. Patients aged between 18 and 70 years; 4. Patients who can cooperate with the completion of the experiment, and can independently record headache diary and fill in the questionnaire scale; 5. Voluntary participants who have signed informed consent.

Exclusion criteria

Exclusion criteria: 1. Other primary headaches, such as migraine and cluster headache; 2. Headache secondary to other diseases, such as hypertension, post-traumatic brain syndrome, intracranial lesions, infections, tuberculosis, and headache caused by drug overuse; 3. Patients with unstable vital signs complicated with serious primary diseases of heart, cerebrovascular, liver, kidney, lung and hematopoietic system; 4. Patients with mental illness; 5. Pregnant or lactating patients; 6. Patients who have taken tension-type headache related drugs (such as analgesics, anti-anxiety and depression drugs, etc.) in the past 1 month; 7. Participating in other clinical trials.

Design outcomes

Primary

MeasureTime frame
Degree of headache;Headache index;

Secondary

MeasureTime frame
Psychomechanical score;Sleep quality assessment;Quality of life;Central Sensitization Inventory-25, CSI-25;Patients' satisfaction degree;Overall efficacy evaluation;Safety evaluation;Total Tenderness Scoring, TTS;Pain Perception Threshold(PPT), Referred Pain Threshold(RPT), Pain Tolerance Threshold(PTT);Assessment of muscle tone and stiffness;Electrophysiological assessment of muscle;Assessment of muscle local circulation status;Serum biochemical indices;

Countries

China

Contacts

Public ContactDu Yuanhao

The First Affiliated Hospital of Tianjin University of Traditional Chinese Medicine

jpjs_cn@sina.com+86 13821820885

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026